Pharmaco-Electroencephalography in Epilepsy Management

Pharmaco-electroencephalography (pharmaco-EEG) integrates the study of antiseizure medication effects with high-resolution electroencephalography (EEG) to characterise drug-induced alterations in brain electrical activity. By applying both traditional visual inspection and quantitative analyses—such as spectral decomposition and connectivity metrics—pharmaco-EEG provides objective biomarkers of treatment efficacy, tolerability and mechanism of action. Resting-state recordings permit the identification of frequency-specific changes that correlate with seizure control, while connectivity measures reveal how drugs modulate neural synchrony in cortical networks. Advances in signal processing and machine learning now allow for optimisation of time-frequency parameters, yielding predictive models of medication response. This approach supports personalised therapy by informing dose adjustments, anticipating adverse effects and refining drug development pathways, with global significance for improving outcomes in refractory and newly diagnosed epilepsy.

Research from Nature Portfolio

Recent studies have demonstrated the power of combining spectral and temporal filtering with machine-learning classifiers on resting-state EEG to predict outcomes following antiseizure medication in temporal lobe epilepsy. By systematically varying frequency bands and time-window lengths, researchers identified an optimal feature set centred on the 39–41 Hz gamma band and a 210 s segmentation window, achieving an area under the curve of approximately 0.79 in distinguishing seizure-free from non-seizure-free patients. These findings establish standardised parameters for quantitative pharmaco-EEG analyses and pave the way for automated tools that can guide clinical decision-making in epilepsy management.

Pharmaco-Electroencephalography in Epilepsy Management publication trend

The graph below shows the total number of articles in pharmaco-electroencephalography in epilepsy management across all publications each year (not limited to Nature Index journals).

Technical terms

Pharmaco-electroencephalography: The integration of pharmacological interventions with EEG recording to assess drug effects on brain electrical activity.

Spectral power density: A quantitative measure of the distribution of signal power across frequency bands within an EEG recording.

Phase locking value (PLV): A metric of functional connectivity quantifying the consistency of phase differences between EEG signals from different brain regions.

Antiseizure medication (ASM): A pharmacological agent used to prevent or reduce the frequency and severity of epileptic seizures.

Resting-state EEG: Recording of spontaneous brain electrical activity while the subject is awake but not engaged in a specific task, used to assess baseline neural dynamics.

References

1. Using spectral and temporal filters with EEG signal to predict the temporal lobe epilepsy outcome after antiseizure medication via machine learning. Scientific Reports (2023).
2. Quantitative EEG analysis of brivaracetam in drug-resistant epilepsy: A pharmaco-EEG study. Clinical Neurophysiology (2024).
3. Cenobamate modulates EEG cortical activity and connectivity in individuals with drug-resistant epilepsy: a pharmaco-EEG study. Frontiers in Neurology (2025).